Health
Headlines
Get
the latest news in prevention and health matters. This
feature includes daily postings and recent archives to
keep you up to date on health reports and wires around
the world.
Weekly
Wellness
Get
informed with weekly wellness facts in a diversity of
health topics from prevention to fitness and nutrition.
Tips
Great
tips on what you need to know about keeping healthy and
active all year round.
Study Examines NSAID
Use And Breast Cancer Risk
Ibuprofen use is associated with an increased
risk of breast cancer, and long-term daily use of
aspirin is associated with an increased risk of
estrogen receptor/progesterone receptor (ER/PR)-negative
breast cancer, according to a new study in the June
1 issue of the Journal of the National Cancer
Institute.
Nonsteroidal anti-inflammatory drugs (NSAIDs),
such as aspirin and ibuprofen, are used to treat
common conditions such as pain and fever and chronic
conditions such as arthritis and are given prophylactically
to reduce the risk of heart attacks and stroke.
Interest has also been growing in using NSAIDs to
prevent cancer. Studies have found an inverse association
between NSAID use and colorectal cancer, but studies
of NSAIDs and breast cancer risk have had mixed
results.
To investigate the association between NSAID use
and breast cancer risk, Sarah F. Marshall, of the
University of Southern California in Los Angeles,
and colleagues analyzed data on 114,460 women in
the California Teachers Study cohort who were ages
22 to 85 and free of cancer at the baseline of the
study, 1995 to 1996. During the follow-up period,
1995 to 2001, 2,391 women were diagnosed with breast
cancer of known receptor status.
Regular use (i.e., more than once a week) of NSAIDs
was not associated with breast cancer risk. However,
long-term daily use of aspirin was associated with
an increased risk of ER/PR-negative breast cancer,
and long-term daily use of ibuprofen was associated
with an increased risk of breast cancer and particularly
nonlocalized cancer.
"These observations warrant further exploration
because of the public health impact such readily
available NSAIDs may have on breast cancer," the
authors write. "Additional large-scale prospective
epidemiologic studies may help clarify the findings
by further examining the long-term effects of aspirin
and ibuprofen, especially with regard to ER/PR-negative
and nonlocalized breast cancer. A more detailed
understanding of the tissue-specific effects of
NSAIDs, particularly in the context of the complex
biological mechanisms involved in the development
of different cancers, is also needed."